Origins of Lynch Syndrome
Although the syndrome is named after the "father of hereditary cancer," it hasn't always been referred to as such.
©Photographee.eu - stock.adobe_.com
Henry Lynch has been considered the "father of hereditary cancer" and a pioneer in the study of cancer and genetics. Dr. Lynch received his doctorate degree in human genetics at the University of Texas, Austin, in 1960, while completing medical school there. In 1966, while a professor at Creighton University, he characterized the syndrome and named "Cancer Family Syndrome." Later in 1984, the term Lynch syndrome was coined by other authors, and in 1985, Dr. Lynch named the condition HNPCC (hereditary nonpolyposis colorectal cancer). Since then, the two names have been used interchangeably. Lynch syndrome families are born with a predisposition to develop colorectal, endometrial ovarian, or other cancers.
For more information on Lynch syndrome: Keys to identifying Lynch syndrome
Study shows a healthy prenatal diet could be upstream obesity prevention strategy
December 26th 2024"Our findings support the recommendation of a healthy diet based on the current guidelines (as measured by the HEI) during pregnancy, since it may reduce patterns of infant growth outside reference ranges."
Read More
S1E4: Dr. Kristina Adams-Waldorf: Pandemics, pathogens and perseverance
July 16th 2020This episode of Pap Talk by Contemporary OB/GYN features an interview with Dr. Kristina Adams-Waldorf, Professor in the Department of Obstetrics and Gynecology and Adjunct Professor in Global Health at the University of Washington (UW) School of Medicine in Seattle.
Listen
Early pregnancy cannabis use high in states with recreational legalization
November 11th 2024A population-based time-series analysis California before, during and after legalization show a rising trend in women using cannabis while pregnancy especially when the state has legalized the drug.
Read More
Similar delivery times between misoprostol dosages among obese patients reported
May 29th 2024A recent study found that obese patients undergoing induction of labor experienced similar delivery times regardless of whether they received 50 μg or 25 μg of vaginal misoprostol, though multiparous patients showed faster delivery with the higher dosage.
Read More
